New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis

Effectiveness Analysis ◽

Anticoagulant Drugs

PCV77 Economic Evaluation of Dabigatran Etexilate 150dib for the Stroke Prevention in Atrial Fibrillation in Greece: A Cost –Effectiveness Analysis under the Greek NHS Setting

Value in Health ◽

10.1016/j.jval.2011.08.797 ◽

2011 ◽

Vol 14 (7) ◽

pp. A378

Author(s):

V. Fragoulakis ◽

T. Theodoratou ◽

N. Maniadakis

Keyword(s):

Atrial Fibrillation ◽

Economic Evaluation ◽

Cost Effectiveness ◽

Stroke Prevention ◽

Dabigatran Etexilate ◽

PND4 Exploratory Cost-Effectiveness Analysis of Thread Embedding Acupuncture Plus Usual Care Versus Usual Care Alone for Treating Sequelae in Bell's Palsy Patients: An Economic Evaluation Alongside a Clinical Trial

Value in Health Regional Issues ◽

10.1016/j.vhri.2020.07.392 ◽

2020 ◽

Vol 22 ◽

pp. S75

Author(s):

N. Kim ◽

M. Park ◽

T. Yook ◽

J. Kim

Keyword(s):

Clinical Trial ◽

Economic Evaluation ◽

Cost Effectiveness ◽

Usual Care ◽

Bell’S Palsy ◽

Bell's Palsy ◽

Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiaries

Current Medical Research and Opinion ◽

10.1080/03007995.2017.1375470 ◽

2017 ◽

Vol 34 (1) ◽

pp. 55-63 ◽

Cited By ~ 3

Author(s):

Siyang Peng ◽

Kristen A. Deger ◽

Anastasia Ustyugova ◽

Pranav Gandhi ◽

Nan Qiao ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Real World ◽

Stroke Prevention ◽

Medicare Beneficiaries ◽

Effectiveness Analysis ◽

Real World Evidence

PCV114 FEASIBILITY OF USING REAL WORLD EVIDENCE TO INFORM DECISIONS ON CONDUCTING A COST EFFECTIVENESS ANALYSIS: AN EXAMPLE OF STROKE RISK REDUCTION THERAPIES IN ATRIAL FIBRILLATION

Value in Health ◽

10.1016/j.jval.2019.09.838 ◽

2019 ◽

Vol 22 ◽

pp. S563

Author(s):

O. Saunders ◽

R.L. Akehurst ◽

Y. Zhong ◽

S.L. Amorosi ◽

M. Gavaghan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Risk Reduction ◽

Real World ◽

Stroke Risk ◽

Effectiveness Analysis ◽

Real World Evidence

Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding

PharmacoEconomics ◽

10.1007/s40273-018-0741-3 ◽

2018 ◽

Vol 37 (2) ◽

pp. 279-289 ◽

Cited By ~ 4

Author(s):

Thananan Rattanachotphanit ◽

Chulaporn Limwattananon ◽

Onanong Waleekhachonloet ◽

Phumtham Limwattananon ◽

Kittisak Sawanyawisuth

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

High Risk ◽

Stroke Prevention ◽

Oral Anticoagulants ◽

Risk Of Bleeding ◽

Effectiveness Analysis ◽

Direct Acting ◽

Direct Acting Oral Anticoagulants

How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?

Value in Health ◽

10.1016/j.jval.2014.08.2509 ◽

2014 ◽

Vol 17 (7) ◽

pp. A675-A676 ◽

Cited By ~ 1

Author(s):

J.M. Höhne ◽

N. Demarteau ◽

Ö. Saka ◽

B. Standaert ◽

J. Kleintjens

Keyword(s):

Economic Evaluation ◽

Cost Effectiveness ◽

Decision Makers ◽

Evaluation Tools ◽

PCV54 Cost-Effectiveness Analysis of Dabigatran Compared to Warfarin for Stroke Prevention in Atrial Fibrillation in a Medicare Population

Value in Health ◽

10.1016/j.jval.2012.03.657 ◽

2012 ◽

Vol 15 (4) ◽

pp. A121

Author(s):

M.A. Ward ◽

A.K. Biddle

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Stroke Prevention ◽

Medicare Population ◽

Economic Evaluation of Safflower Yellow Injection for the Treatment of Patients with Stable Angina Pectoris in China: A Cost-Effectiveness Analysis

The Journal of Alternative and Complementary Medicine ◽

10.1089/acm.2017.0284 ◽

2018 ◽

Vol 24 (6) ◽

pp. 564-569

Author(s):

Jianwei Xuan ◽

Min Huang ◽

Yongji Lu ◽

Libo Tao

Keyword(s):

Economic Evaluation ◽

Cost Effectiveness ◽

Angina Pectoris ◽

Stable Angina ◽

Stable Angina Pectoris ◽

PCV5 Cost-Effectiveness Analysis of Apixaban in Treatment of Atrial Fibrillation: A Systematic Review

Value in Health Regional Issues ◽

10.1016/j.vhri.2020.07.023 ◽

2020 ◽

Vol 22 ◽

pp. S26-S27

Author(s):

D. Tran ◽

C. Nguyen ◽

T. Nguyen

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Cost Effectiveness ◽

Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation—results for Canada, Italy, Sweden and Switzerland

The European Journal of Health Economics ◽

10.1007/s10198-012-0391-x ◽

2012 ◽

Vol 14 (3) ◽

pp. 481-493 ◽

Cited By ~ 2

Author(s):

Jonas Nilsson ◽

Örjan Åkerborg ◽

Gaëlle Bégo-Le Bagousse ◽

Mårten Rosenquist ◽

Peter Lindgren

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽